Lemaitre Vascular (LMAT) FY2015 results: revenue $78 million, up 10.2% on the year
Lemaitre Vascular Inc. (LMAT) reported revenue of $78 million for fiscal 2015, the year ended 31 December 2015, up 10.2% on the year before. Net income was $8 million, up 98.2%, and diluted earnings per share $0.42. The figures are the company's own, from the 10-K it filed with the SEC on 10 March 2016.
Revenue
$78 million
+10.2% on the year
FY2009FY2015
Operating margin
14.7%
8.9% a year earlier
FY2009FY2015
Net income
$8 million
+98.2% on the year
FY2009FY2015
Diluted EPS
$0.42
+82.6% on the year
FY2009FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
78.4
71.1
64.5
+10.2%
Cost of revenue
24.2
22.7
19.4
+6.7%
Gross profit
54.2
48.4
45.1
+11.8%
Gross margin
69.1%
68.1%
69.9%
Research and development
5.5
4.7
5.2
+17.3%
Operating income
11.5
6.3
4.5
+81.6%
Operating margin
14.7%
8.9%
7.0%
Interest expense
n/a
0.0
0.0
Pre-tax income
11.4
6.3
4.3
+80.8%
Income tax
3.7
2.4
1.1
+52.4%
Effective tax rate
32.1%
38.1%
26.0%
Net income
7.8
3.9
3.2
+98.2%
Net margin
9.9%
5.5%
5.0%
Diluted EPS
$0.42
$0.23
$0.20
+82.6%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
11.4
5.5
5.4
+107.5%
Capital expenditure
2.3
1.2
2.7
+93.6%
Free cash flow
9.2
4.3
2.7
+111.3%
Free cash flow margin
11.7%
6.1%
4.1%
Cash from investing
n/a
n/a
-6.2
Cash from financing
n/a
n/a
-1.0
Depreciation and amortisation
3.4
3.3
2.8
+1.8%
Share-based compensation
1.4
1.3
1.3
+9.4%
Buybacks
0.3
0.2
0.4
+26.1%
Dividends paid
2.8
2.3
1.8
+23.3%
Dividend per share
$0.16
$0.14
$0.12
+14.3%
Diluted shares, weighted
18m
17m
16m
+7.7%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
77.9
68.2
56.6
+14.2%
Debt
0.0
0.0
0.0
Other liabilities
12.8
13.3
13.9
-3.5%
Total liabilities and equity
90.7
81.5
70.5
+11.3%
Fixed assets
7.0
6.9
5.8
+2.1%
Goodwill
17.8
17.3
15.0
+2.9%
Intangible assets
6.3
7.2
6.1
-11.5%
Cash and equivalents
27.5
18.7
14.7
+46.9%
Receivables
12.0
10.8
10.6
+10.8%
Inventory
15.2
16.7
13.3
-9.0%
Other assets
4.9
4.0
5.0
+24.3%
Total assets
90.7
81.5
70.5
+11.3%
10-K for the year ended 31 December 2015, filed 10 March 2016: the filing.